Industrial & Pharmaceutical Raw MaterialsThe Right Source
Home / Products / Riboflavin-5′-Phosphate Sodium
Active pharmaceutical ingredients

Riboflavin-5′-Phosphate Sodium

Riboflavin phosphate ingredient for pharmaceutical formulation

Riboflavin-5′-phosphate sodium is a phosphorylated vitamin B₂ derivative. The published USP identity includes the dihydrate; hydration state and the riboflavin-equivalent assay basis require explicit confirmation.

CAS
130-40-5 (anhydrous)
Molar mass
514.36 g/mol (dihydrate)
Form
Phosphated vitamin B₂ salt
Riboflavin-5′-Phosphate Sodium
Riboflavin-5′-Phosphate Sodium
Anhydrous riboflavin phosphate sodium structure; hydrate water is not depicted.
Anhydrous riboflavin phosphate sodium structure; hydrate water is not depicted.
Product overview

Understanding the material

Select the material by its full chemical name and agreed quality specification. Published identity information helps define the enquiry; batch quality, physical grade, packing and availability are confirmed through the current manufacturer documentation and SBS quotation.

Identity & properties

Product Identity & Specifications

Chemical identity, physical characteristics and key specifications for Riboflavin-5′-Phosphate Sodium.

ParameterDescription / valueBasis / application
Product identityRiboflavin-5′-Phosphate SodiumSpecify the complete product name.
CAS number130-40-5 (anhydrous)Published identity reference
Molecular formulaC₁₇H₂₀N₄NaO₉P·2H₂OSalt / hydrate basis shown
Molecular weight514.36 g/mol (dihydrate)For the formula shown
Physical gradePhosphated vitamin B₂ saltConfirm the offered grade and particle characteristics.
Assay and impuritiesCurrent specification and batch COARead the calculation basis with water and solvent results.
Packaging and retestManufacturer-specificConfirm in the quotation and batch documents.

Identity and published standard

USP–NF published identity

Use the linked reference to review the chemical identity. The applicable edition and complete quality specification must be agreed for the offered material.

View identity reference

A public identity reference is not evidence that an offered batch complies with a pharmacopoeia.

For further information and current COA/specification, please contact us.

Request current COA & specification
Where it is used

Applications & functional benefits

01

Formulation development

Assess the API in the intended dosage form, using qualified development material and a defined specification.

02

Manufacturing qualification

Review the source, analytical methods and batch documentation before commercial process qualification.

03

Procurement evaluation

Send your target specification, quantity and destination so SBS can review a suitable sourcing proposal.

Choose the right material

Identity, physical grade and specification

Selection pointMaterial / requirementBuyer review
Chemical identityPhosphated vitamin B₂ saltConfirm the exact salt or hydrate in the purchase specification.
Physical gradeParticle distribution and bulk characteristicsAgree measurable limits and test methods for the intended process.
Quality standardRequired pharmacopoeia or agreed specificationReview the current specification, COA and supporting documentation.
Manufacturing considerations

Formulation & processing

Product-specific considerations

Review light protection, particularly for solutions, and moisture control during handling. Do not treat a riboflavin-equivalent assay as a direct percentage of the complete sodium salt.

Batch calculations

Use the stated assay basis and current batch results in the approved manufacturing calculation. Distinguish salt or hydrate mass from equivalent active content.

Process suitability

Confirm compatibility and finished-product quality in the complete formulation; a material name or assay result alone does not establish process suitability.

Quality review

What to check in the specification

  • Identity of the active ingredient, salt and hydration state
  • Assay method and calculation basis
  • Specified, unspecified and total related substances
  • Water or loss on drying and residual solvents
  • Particle characteristics and microbiological requirements appropriate to the process

Current product documentation

Request the current batch COA, complete specification, SDS and stability/retest information. Discuss manufacturer qualification and applicable regulatory-support documents for your intended market.

Request documents for Riboflavin-5′-Phosphate Sodium
Supply & handling

Packing, storage & handling

Packing and quotation details

Confirm pack size, inner liner, container type, batch traceability, quantity and delivery terms with the quotation. No standard pack size or stock availability is implied.

Storage and safe handling

Keep the original container closed and protected from contamination. Follow the manufacturer’s labelled storage conditions, retest date and SDS; agree additional light or moisture protection where required.

Product questions

Frequently asked questions

What should an enquiry include?

Required grade, dosage form, specification, quantity and delivery destination.

Are specifications and documents available?

Request the current batch COA, complete specification, SDS and stability/retest information. Discuss manufacturer qualification and applicable regulatory-support documents for your intended market.

Is the supplied API automatically suitable for every dosage form?

No. Suitability depends on the offered grade, impurity and microbiological controls, intended route and validated manufacturing process.

Technical information sources

Need more information?

Contact SBS for further product details, current COA, specification, packing and a quotation for your requirement.

Contact SBS for details and documents